Melanoma 2019: 29th Annual Cutaneous Malignancy Update
Intralesional Oncolytic Immunotherapy in Melanoma: Update on OPTiM Study on T-VEC for Unresectable Melanoma
Login to view comments.
Click here to Login
Videos